Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 70.0 | 60 | ||||
N2645 | 2 | MIP-1B | 59.5 | 60 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 71.0 | 46 | ||||
RA2708 | 2 | MIP-1B | 70.0 | 59 | |||||||
0 | MIP-1B | 66.5 | 54 | ||||||||
0 | MIP-1B | 70.5 | 66 | ||||||||
0 | MIP-1B | 71.0 | 47 | ||||||||
0 | MIP-1B | 58.5 | 74 | ||||||||
0 | MIP-1B | 53.0 | 67 | ||||||||
0 | MIP-1B | 56.5 | 24 | ||||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIP-1B | 52.0 | 75 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | MIP-1B | 51.0 | 75 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIP-1B | 51.0 | 76 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | MIP-1B | 50.0 | 66 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIP-1B | 56.0 | 95 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | MIP-1B | 54.0 | 77 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIP-1B | 55.0 | 61 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | MIP-1B | 53.0 | 73 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | MIP-1B | 53.5 | 54 | ||||
RA1869 | 3 | MIP-1B | 50.0 | 67 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | MIP-1B | 50.0 | 70 | ||||
N2759 | 3 | MIP-1B | 57.0 | 69 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | MIP-1B | 52.0 | 79 | ||||
RA1931 | 3 | MIP-1B | 55.0 | 65 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | MIP-1B | 58.0 | 79 |